Dupont Jakob 4
4 · Bolt Biotherapeutics, Inc. · Filed Sep 6, 2024
Insider Transaction Report
Form 4
Dupont Jakob
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-03+16,984→ 16,984 totalExercise: $0.68Exp: 2034-09-02→ Common Stock (16,984 underlying) - Award
Stock Option (Right to Buy)
2024-09-03+50,000→ 50,000 totalExercise: $0.68Exp: 2034-09-02→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following September 3, 2024; provided, however that the option will vest in full upon a change in control.
- [F2]The shares subject to this option shall vest in full on the date immediately preceding the date of the Issuer's next annual stockholder meeting for so long as the Reporting Person is serving as a director of the Issuer on such date; provided, however that the option will vest in full upon a change in control.